The Microbiology of Caries Resistance

Sponsor
University of Florida (Other)
Overall Status
Completed
CT.gov ID
NCT02130206
Collaborator
Colgate Palmolive (Industry)
79
1
4
6
13.1

Study Details

Study Description

Brief Summary

The purpose of this research study is to investigate the bacterial composition of plaque and saliva located in the mouth and associate that with risk factors that cause cavities.

Condition or Disease Intervention/Treatment Phase
  • Other: Caries Free
  • Other: Caries Active
  • Other: Caries Free - Placebo
  • Other: Caries Active - Placebo
Phase 2

Detailed Description

Pre-Screening - If the subject chooses to be pre-screened for this study they will be asked to fill out a study registration form and an oral habits/medical history form. They will be asked to sign an Informed Consent. The subject will then have their teeth and gums examined. At this visit, the investigator will assess whether or not the subject is a good candidate for the study. During the phone interview each subject was asked not to brush or floss their teeth and not to eat or drink anything other than water for 8 hours prior to the pre-screening visit (Visit 0). If the subject was compliant with these requests, oral samples will be collected at this pre-screening visit and will now be considered Visit 1 (Baseline). If not, they will be asked to return to the clinic for another visit and asked not to brush or floss their teeth and not to eat or drink anything other than water 8 hours prior to that appointment. This visit will then be consider Visit 1 (Baseline).

Visit 1 (Baseline) - The subject will have their medical and dental history reviewed. They will have their teeth and gums examined. Saliva and plaque will be collected. Each subject will be given a toothbrush and toothpaste and instructed to not use any other dental products. This will be considered the "washout" period.

Visit 2 - The subject will be asked to return the unused toothpaste. Their medical and dental history will be reviewed and they will have their teeth examined. Saliva and plaque will be collected at this visit. The subjects will then be randomly assigned (by chance, like the flip of a coin) to the group that will use a marketed fluoride-containing toothpaste or to the group that will use a marketed arginine containing toothpaste. The subject will also be instructed not to brush or floss their teeth or eat or drink anything other than water for 8 hours prior to your next appointment.

Visits 3, 4, and 5 - Subjects will not be allowed to brush or floss their teeth or eat or drink anything other than water 8 hours prior to these visits. Saliva and plaque will be collected. On the 5th visit subjects will be asked to return the unused toothpaste tube. At this time participation in this research study will end and they will be instructed to return to their regular oral hygiene regiments.

Study Design

Study Type:
Interventional
Actual Enrollment :
79 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Diagnostic
Official Title:
The Microbiology of Caries Resistance. Subtitle: Functional Amyloid Formation in Streptococcus Mutans
Study Start Date :
May 1, 2014
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Nov 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Caries Free

Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.

Other: Caries Free
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.

Placebo Comparator: Caries Free - Placebo

Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.

Other: Caries Free - Placebo
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.

Active Comparator: Caries Active

Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.

Other: Caries Active
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.

Placebo Comparator: Caries Active - Placebo

Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.

Other: Caries Active - Placebo
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.

Outcome Measures

Primary Outcome Measures

  1. Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from baseline to month 2 [Changes from baseline to month 2 (Screening)]

    Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.

  2. Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from month 2 to week 4 [Changes from month 2 to week 4 (Baseline)]

    Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.

  3. Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 4 to week 2 [Changes from week 4 to week 2 (Washout)]

    Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.

  4. Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 2 to week 8 [Changes from week 2 to week 8 (Evaluation)]

    Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.

  5. Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 8 to week 12 [Changes from week 8 to week 12 (Evaluation)]

    Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.

Secondary Outcome Measures

  1. Bacteria collected from oral samples of healthy and caries-active subjects changes from baseline to month 2 [Changes from baseline to month 2 (Screening)]

    Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.

  2. Bacteria collected from oral samples of healthy and caries-active subjects changes from month 2 to week 4 [Changes from month 2 to week 4 (Baseline)]

    Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.

  3. Bacteria collected from oral samples of healthy and caries-active subjects changes from week 4 to week 2 [Changes from week 4 to week 2 (Washout)]

    Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.

  4. Bacteria collected from oral samples of healthy and caries-active subjects changes from week 2 to week 8 [Changes from week 2 to week 8 (Evaluation)]

    Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.

  5. Bacteria collected from oral samples of healthy and caries-active subjects changes from week 8 to week 12 [Changes from week 8 to week 12 (Evaluation)]

    Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.

Other Outcome Measures

  1. Salivary factors present in healthy and caries-active subjects during the research study. [Up to six months.]

    Saliva will be collected from healthy and caries-active subjects during the research study. Microbiological and molecular techniques such as microscopic observation of green birefringence, elisa assays and microRNA analysis will be used to determine and compare differences between salivary factors present in these two groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Twenty natural teeth excluding third molars

  • No contraindications to dental treatment

  • Caries Free

  • Caries Active (at least two active sites)

Exclusion Criteria:
  • Less that twenty teeth

  • Any systemic disease that can cause xerostomia

  • Taking medications that cause xerostomia

  • Antibiotics last three months

  • Advanced Periodontal Disease

  • Removable or fixed dental appliances

  • Bleeding disorders or taking anticoagulant medications

  • Immune compromised individuals

  • Participating in another research study

  • Used flavored products such as mint flavored candies and chewing gum one week prior to or during the study

  • Uses tobacco products

  • Unwilling or unable to provide Informed Consent and follow collection instructions

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Florida College of Dentistry Gainesville Florida United States 32610

Sponsors and Collaborators

  • University of Florida
  • Colgate Palmolive

Investigators

  • Principal Investigator: Marcelle Nascimento, DDS, MS, PhD, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT02130206
Other Study ID Numbers:
  • 665-2008
  • A-2013-197-OC
First Posted:
May 5, 2014
Last Update Posted:
Nov 9, 2016
Last Verified:
Nov 1, 2016
Keywords provided by University of Florida
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2016